Clinical Trial Detail

NCT ID NCT02343718
Title Vinblastine and Temsirolimus in Pediatric Patients With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors NCIC Clinical Trials Group
Indications

Advanced Solid Tumor

lymphoma

malignant glioma

Therapies

Temsirolimus + Vinblastine

Age Groups: child

No variant requirements are available.